Inactive Instrument

Other languages Perrigo Company Nasdaq

Equities

US7142901039

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 25	Sector Update: Health Care Stocks Decline Late Afternoon	MT
Apr. 25	Perrigo Receives Binding Offer to Sell HRA Pharma Rare Diseases Business for Up to $295 Million	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Decline Late Afternoon	Apr. 25
Perrigo Receives Binding Offer to Sell HRA Pharma Rare Diseases Business for Up to $295 Million	Apr. 25
CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors	Apr. 04
Multiple CVS Caremark Plans to Cover Perrigo's Opill at No Cost	Apr. 04
Sector Update: Health Care Stocks Rise Late Afternoon	Mar. 19
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading	Mar. 19
Perrigo Shares Rise After Wisconsin Governor Makes Birth Control Pill Free for Medicaid Members	Mar. 19
Perrigo Company plc Announces Erica L. Mann Not to Stand for Re-Election to its Board of Directors	Mar. 06
Perrigo Company plc Commences Shipments of Opill to Retailers Nationwide, Empowering Millions to Enter A New Era of Reproductive Health Access in the United States	Mar. 04
Perrigo Co Insider Bought Shares Worth $252,168, According to a Recent SEC Filing	Feb. 29
Perrigo Company plc Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27
Sector Update: Health Care Stocks Mixed Premarket Tuesday	Feb. 27
Sector Update: Health Care	Feb. 27
Perrigo Q4 Adjusted Earnings Increase, Net Sales Flat	Feb. 27
Perrigo Company plc Reports Earnings Guidance for the Fiscal Year 2024	Feb. 27
Perrigo Company plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27
Perrigo Company plc Increases its Quarterly Dividend, Payable on March 26, 2024	Feb. 26
Perrigo Co Insider Bought Shares Worth $172,106, According to a Recent SEC Filing	Nov. 28
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	Nov. 07
Perrigo's Q3 Adjusted Earnings, Net Sales Rise; 2023 Reported Net Sales Guidance Lowered	Nov. 07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Perrigo Company Nasdaq

Equities

US7142901039

Other languages

Filters